Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 13.54%517.16M | 5.12%966.82M | -1.42%455.47M | 0.23%919.68M | 3.75%462.03M | 3.62%917.57M | 3.67%445.33M | 15.94%885.54M | 26.37%429.57M | 58.62%763.81M |
| Operating income | 13.54%517.16M | 5.12%966.82M | -1.42%455.47M | 0.23%919.68M | 3.75%462.03M | 3.62%917.57M | 3.67%445.33M | 15.94%885.54M | 26.37%429.57M | 58.62%763.81M |
| Cost of sales | -15.49%-462.12M | -0.71%-851.55M | 1.36%-400.16M | -7.36%-845.54M | -8.28%-405.68M | -3.77%-787.58M | -1.31%-374.67M | -17.38%-758.95M | -31.66%-369.83M | -58.72%-646.56M |
| Operating expenses | -15.49%-462.12M | -0.71%-851.55M | 1.36%-400.16M | -7.36%-845.54M | -8.28%-405.68M | -3.77%-787.58M | -1.31%-374.67M | -17.38%-758.95M | -31.66%-369.83M | -58.72%-646.56M |
| Gross profit | -0.51%55.04M | 55.46%115.26M | -1.83%55.32M | -42.96%74.14M | -20.24%56.35M | 2.69%129.99M | 18.27%70.65M | 7.97%126.59M | 1.22%59.74M | 58.08%117.25M |
| Selling expenses | -45.23%-21.71M | -36.78%-38.44M | -27.52%-14.95M | -32.99%-28.11M | -28.60%-11.72M | -37.12%-21.13M | -32.04%-9.12M | -21.74%-15.41M | -82.04%-6.9M | -34.76%-12.66M |
| Administrative expenses | -4.38%-36.42M | -0.52%-119.32M | 4.49%-34.89M | -46.96%-118.7M | 9.79%-36.54M | -14.02%-80.77M | -6.78%-40.5M | 1.47%-70.84M | -16.07%-37.93M | -23.96%-71.9M |
| Revaluation surplus | ---- | 74.29%-12.43M | 50.62%-3M | -822.42%-48.34M | ---6.08M | ---5.24M | ---- | ---- | ---- | ---- |
| -Changes in the fair value of investment property | ---- | 74.29%-12.43M | 50.62%-3M | -822.42%-48.34M | ---6.08M | ---5.24M | ---- | ---- | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | -213.73%-6.67M | 15.30%-4.99M | 27.82%-2.13M | ---5.89M |
| Special items of operating profit | 281.31%8.75M | -58.49%11.07M | -44.21%2.3M | 85.99%26.67M | 61.08%4.11M | -35.06%14.34M | -83.76%2.55M | 126.47%22.08M | 210.65%15.72M | 44.63%9.75M |
| Operating profit | 18.59%5.66M | 53.51%-43.86M | -22.16%4.77M | -353.72%-94.33M | -63.77%6.13M | -35.26%37.18M | -40.64%16.92M | 57.13%57.43M | 15.56%28.5M | 170.41%36.55M |
| Financing cost | 15.73%-6.64M | -8.47%-16.12M | -9.55%-7.88M | -8.65%-14.86M | ---7.19M | ---13.68M | ---- | ---- | ---- | ---- |
| Share of profits of associates | 6.62%6.1M | 52.48%13.82M | 7.01%5.72M | 17.31%9.06M | 28.26%5.35M | -26.72%7.73M | -40.13%4.17M | -10.43%10.54M | 10.82%6.96M | 71.01%11.77M |
| Share of profit from joint venture company | -2.10%1.49M | 150.98%1.65M | 226.85%1.53M | -636.05%-3.23M | -222.51%-1.2M | -78.10%602K | -46.98%982K | 166.12%2.75M | -22.38%1.85M | -79.67%1.03M |
| Earning before tax | 59.80%6.61M | 56.93%-44.51M | 34.41%4.14M | -424.70%-103.36M | -86.05%3.08M | -54.99%31.83M | -40.86%22.07M | 43.30%70.72M | 11.95%37.32M | 107.32%49.35M |
| Tax | -1,385.89%-4.74M | -125.14%-5.63M | 74.11%-319K | 416.99%22.41M | 75.25%-1.23M | 60.13%-7.07M | 34.83%-4.98M | -43.20%-17.73M | -3.90%-7.64M | -272.62%-12.38M |
| After-tax profit from continuing operations | -51.00%1.87M | 38.05%-50.15M | 106.83%3.82M | -426.90%-80.95M | -89.20%1.85M | -53.27%24.76M | -42.42%17.09M | 43.33%52.99M | 14.22%29.68M | 80.50%36.97M |
| Earning after tax | -51.00%1.87M | 38.05%-50.15M | 106.83%3.82M | -426.90%-80.95M | -89.20%1.85M | -53.27%24.76M | -42.42%17.09M | 43.33%52.99M | 14.22%29.68M | 80.50%36.97M |
| Minority profit | 91.02%2.75M | 103.01%195K | -6.93%1.44M | -153.00%-6.49M | -72.18%1.54M | -15.00%12.24M | -11.06%5.55M | 33.81%14.4M | -19.93%6.24M | 301.61%10.76M |
| Profit attributable to shareholders | -136.71%-874K | 32.39%-50.34M | 688.41%2.38M | -694.52%-74.46M | -97.38%302K | -67.54%12.53M | -50.77%11.54M | 47.24%38.59M | 28.86%23.44M | 47.23%26.21M |
| Basic earnings per share | 31.58%-0.13 | 0.01 | -733.33%-0.19 | -70.00%0.03 | -40.00%0.03 | 42.86%0.1 | 25.00%0.05 | 75.00%0.07 | ||
| Diluted earnings per share | 31.58%-0.13 | 0.01 | -733.33%-0.19 | -70.00%0.03 | -40.00%0.03 | 42.86%0.1 | 25.00%0.05 | 75.00%0.07 | ||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.